[email protected]/(408) 457-3700

About Rani Therapeutics

Rani Therapeutics has developed a novel approach for the oral delivery of large drug molecules including peptides, proteins and antibodies. We are currently in pre-clinical studies and have demonstrated greater than 50% bioavailability. View a snapshot of our results with Adalimumab and human insulin.

We are currently exploring partnerships with pharmaceutical companies. Contact us to learn more about our innovation and approach.

Recent Status Updates

Dec, 18 2015 5:50 pm
fashdflkjashdf
Dec, 17 2015 5:43 pm
Rani Therapeutics Secures Series C Funding
Dec, 17 2015 5:43 pm
Rani Therapeutics™ announces Collaboration with Major Pharmaceutical Company
Dec, 17 2015 5:43 pm
Robotic Pills Could Simplify Administration of Biologic Drugs
Dec, 17 2015 5:43 pm
Rani & Mir Imran Featured in OnDrugDelivery

You need to register as an accredited investor before we can show you the details of any investment opportunities.

VentureHealth is currently invite only.

Request An Invite!

Startup's Info

Location:
San Jose
Markets:
Biotechnology, Medical Devices, Pharmaceuticals
Therapeutic Areas:
Gastroenterology, Hematology, Immunology, Other, Vaccines